New Agreement - Zydus Lifesciences Ltd

Code BSE: 532321 NSE:

Zydus Pharmaceuticals USA Inc., USA, a wholly owned subsidiary of Zydus Lifesciences Limited has entered into a definitive agreement with Agenus West LLC, and Agenus Inc., USA (collectively referred to as “Agenus”), to acquire, directly or through its affiliates, two U.S. based biologics manufacturing facilities of Agenus, one in Emeryville, CA and another in Berkeley, CA ,the Target Assets. We hereby now inform that ZPUI has incorporated a wholly owned subsidiary in the name of a Zylidac Bio LLC on July 11, 2025. Zylidac will be acquiring the Target Assets of Agenus.